Increased [3H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia

Neuropsychobiology

Volumn 45, Issue 1, 2002, Pages 7-11

  Sundman Eriksson, Ingrid ^a   Blennow, Kaj ^b   Davidsson, Pia ^b   Dandenell, Anna Karin ^c   Marcusson, Jan ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Health University   (Sweden)

Author keywords

Caudate nucleus; Cingulate cortex; GABA; GAT 1; Schizophrenia; Tiagabine

Indexed keywords

4 AMINOBUTYRIC ACID; GAT 1; TIAGABINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BINDING SITE; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; GABAERGIC TRANSMISSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; SCHIZOPHRENIA;

AGED; AGED, 80 AND OVER; BRAIN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CHRONIC DISEASE; FEMALE; GABA AGONISTS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HUMANS; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; ORGANIC ANION TRANSPORTERS; SCHIZOPHRENIA; UP-REGULATION;

EID: 0036162094     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048666     Document Type: Article

References (34)

1. The biological basis of schizophrenia: New directions
2. Effect of vigabatrin on striatal dopamine receptors: Evidence in humans for interactions of GABA and dopamine systems
3. 123I-iomazenil SPECT study
4. Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia
5. Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia - A study group report
6. Benzodiazepines in the treatment of schizophrenia: A review and reappraisal
7. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients
8. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
9. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia
10. 2O PET study during single-trial Stroop task performance
11. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia
12. Schizophrenia, psychosis and the basal ganglia
13. Uptake of γ-amino-butyric acid and glycine by synaptosomes from postmortem human brain
14. Synthesis of γ-aminobutyric acid from a pool of glutamic acid in brain after decapitation
15. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other atrophies
16. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and in patients with Parkinson's disease and Huntington's chorea
17. Distribution of GABA-T-intensive neurons in the rat forebrain and midbrain
18. 3H]Tiagabine binding to GABA uptake sites in human brain
19. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
20. Localization of messenger RNAs encoding three GABA transporters in rat brain: An in situ hybridization study
21. Distribution of mRNA for the GABA transporter GAT-1 in the rat brain: Evidence that GABA uptake is not limited to presynaptic neurons
22. 67) mRNA localization
23. GAT-1, a high affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex
24. Synaptic degeneration in thalamus in schizophrenia
25. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains
26. Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia
27. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics
28. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
29. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia
30. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia
31. Absence of basal ganglia amino acid neuron deficits in schizophrenia in three collections of brains
32. Reduction of cortical volume in schizophrenia on magnetic resonance imaging
33. Clinical subtypes of schizophrenia: Differences in brain and CSF volume